Overview of Dr. Reidy
Dr. Diane Reidy is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 17 years. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 88 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She also speaks multiple languages, including Spanish. She has more than 100 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2005
State University of New York Downstate Medical Center College of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2002 - 2026
NJ State Medical License 2020 - 2025
OK State Medical License 2020 - 2021
Clinical Trials
- A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors Start of enrollment: 2008 Aug 01
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery Start of enrollment: 2009 Feb 01
- Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET) Start of enrollment: 2010 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.Shah, R., Chou, J., Kundra, R., Punn, S., Fiedler, L., DeMore, A., Capanu, M., Berger, M., Cowzer, D., Reidy-Lagunes, D., Raj, N.> ;Endocrine-Related Cancer. 2024 Apr 1
- ASO Visual Abstract: Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic, Well-Differentiated, Small-Bowel Neuroendocrine Tumors.Li, J., Fiasconaro, M., Lin, S., Capanu, M., Kleiman, D., Nigam, A., Memeh, K., Raj, N., Reidy-Lagunes, D., Untch, B.> ;Annals of Surgical Oncology. 2024 Apr 1
- 1 citationsMorbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors.Aradhya Nigam, Janet W Y Li, Megan Fiasconaro, Sabrina Lin, Marinela Capanu, David A Kleiman, Kelvin Memeh, Nitya Raj, Diane L Reidy-Lagunes, Brian R Untch> ;Annals of Surgical Oncology. 2024 Apr 1
- Join now to see all
Journal Articles
- Biodistribution and Radiation Dose Estimates for 68Ga-DOTA-JR11 in Patients with Metastatic Neuroendocrine TumorsSimone Krebs, Lisa Bodei, Diane Reidy, Bradley J Beattie, Wolfgang A Weber, European Journal of Nuclear Medicine and Molecular Imaging
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
The Pandemic Is Leading to Missed Cancer Diagnoses, New Data WarnsDecember 17th, 2021- Westchester Healthcare Matures During the Coronavirus PandemicMay 26th, 2020
Ipsen : Neuroendocrine Tumor (NET) Expert CallMay 3rd, 2018- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York- Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
